Literature DB >> 8100485

Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.

R Darley1, A Morris, J Passas, W Bateman.   

Abstract

The cell-surface expression of major histocompatibility (MHC) antigens and the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) is essential for target cell recognition by T lymphocytes. The expression of both classes of molecule is induced by various cytokines, notably interferon gamma (IFN gamma). Since transforming growth factor beta (TGF beta) has been recently reported to antagonise HLA-DR induction by IFN gamma we have examined, using a number of murine and human cell lines, the effect of TGF beta on IFN gamma-induced MHC class I and class II and ICAM-1 expression. All of the cell lines tested expressed elevated class I MHC following IFN gamma treatment. Class II MHC induction was seen on most but not all of the cells, the exceptions being among a panel of human colorectal carcinoma cell lines. A striking difference between cells of different origin was noted in the response to TGF beta. TGF beta was found to antagonise IFN gamma-induced class I and class II MHC expression on C3H 10T1/2 murine fibroblasts, early-passage BALB/c mouse embryo fibroblasts, a murine oligodendroglioma cell line, and on MRC5 human fibroblasts and two human glioblastoma cell lines. Class II MHC was much more strongly inhibited (sometimes completely) than class I MHC. TGF beta also inhibited induction of class I MHC expression by IFN alpha. However, TGF beta did not inhibit class I or class II MHC induction by IFN gamma in any of the nine colorectal carcinoma cell lines, although two of five of the lines tested were growth-inhibited by TGF beta. On the other hand, human ICAM-1 induction by IFN gamma was not affected by simultaneous treatment with TGF beta in any of the cell lines. The down-regulation of IFN gamma-induced MHC antigens by TGF beta is not, therefore, the result of a general antagonism of IFN gamma. Retinoic acid has recently been reported to induce ICAM-1 expression on human tumour cells. We have confirmed this observation on MRC5, and the two human glioblastoma cell lines, however six colorectal carcinoma cell lines tested did not respond. In contrast to IFN gamma-induced ICAM-1 expression, retinoic-acid-induced ICAM-1 expression was inhibited by TGF beta on two of the three responsive lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100485     DOI: 10.1007/bf01517043

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  34 in total

1.  Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.

Authors:  T Tada; S Ohzeki; K Utsumi; H Takiuchi; M Muramatsu; X F Li; J Shimizu; H Fujiwara; T Hamaoka
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

2.  Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha.

Authors:  H J Schluesener
Journal:  J Neuroimmunol       Date:  1990-04       Impact factor: 3.478

Review 3.  The cell biology of transforming growth factor beta.

Authors:  J A Barnard; R M Lyons; H L Moses
Journal:  Biochim Biophys Acta       Date:  1990-06-01

4.  Transforming growth factor beta 1 (TGF-beta 1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-beta 1-growth stimulated colon carcinoma cells.

Authors:  Z Yan; S Hsu; S Winawer; E Friedman
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

5.  Immunosuppressive effects of transforming growth factor beta: inhibition of the induction of Ia antigen on Langerhans cells by cytokines and of the contact hypersensitivity response.

Authors:  S P Epstein; R L Baer; G J Thorbecke; D V Belsito
Journal:  J Invest Dermatol       Date:  1991-06       Impact factor: 8.551

6.  A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

Authors:  G Torre-Amione; R D Beauchamp; H Koeppen; B H Park; H Schreiber; H L Moses; D A Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Immunohistological relation between DR antigen expression on melanoma cells and infiltration by CD8+ T cells.

Authors:  P Hersey; O Jamal
Journal:  Pathology       Date:  1990-07       Impact factor: 5.306

8.  Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

Authors:  C W Czarniecki; H H Chiu; G H Wong; S M McCabe; M A Palladino
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

9.  Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.

Authors:  R J Coffey; A S Goustin; A M Soderquist; G D Shipley; J Wolfshohl; G Carpenter; H L Moses
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

10.  Transcripts for transforming growth factors in human breast cancer: clinical correlates.

Authors:  P Barrett-Lee; M Travers; Y Luqmani; R C Coombes
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

View more
  6 in total

1.  Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.

Authors:  Thomas Schneider; Michael Sailer; Siegfried Ansorge; Raimund Firsching; Dirk Reinhold
Journal:  J Neurooncol       Date:  2006-04-14       Impact factor: 4.130

2.  Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization.

Authors:  J C Rockett; K Larkin; S J Darnton; A G Morris; H R Matthews
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 3.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

4.  Sequential changes in MHC antigen expression induced by the v-Ki-ras oncogene.

Authors:  R L Darley; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

5.  Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex.

Authors:  Diego Ottaviani; Elliott Lever; Richard Mitter; Tania Jones; Tim Forshew; Rossitza Christova; Eleni M Tomazou; Vardhman K Rakyan; Stephen A Krawetz; Adrian E Platts; Badmavady Segarane; Stephan Beck; Denise Sheer
Journal:  Genome Res       Date:  2008-10-10       Impact factor: 9.043

6.  The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cells.

Authors:  M J Zimmerman; G R Radford-Smith; D P Jewell
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.